Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Glioblastoma 5Breast Neoplasms 3Brain Neoplasms 2Rectal Neoplasms 1Polycystic Ovary Syndrome 1Non-alcoholic Fatty Liver Disease 1Multiple Myeloma 1Intermittent Fasting 1Fatty Liver 1Estrogen Receptor-positive Breast Cancer 1Endometrial Neoplasms 1Drug Resistant Epilepsy 1Autism Spectrum Disorder 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 46Paclitaxel 42Carboplatin 34Bevacizumab 18Specimen Handling 17Letrozole 16lenvatinib 13Magnetic Resonance Spectroscopy 12dostarlimab 11Cisplatin 11Biopsy 11olaparib 10Taxes 10Fulvestrant 9Doxorubicin 9abemaciclib 8Megestrol Acetate 8Docetaxel 8durvalumab 7atezolizumab 7Nivolumab 7Gemcitabine 7Blood Specimen Collection 7palbociclib 6Oxaliplatin 6Observation 6Fluorouracil 6niraparib 5Tirzepatide 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Diet, Ketogenic × 1 year × Clear all
NCT03285152 2025-09-03

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
19 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡